Scoping review of anticancer drug utilization in lung cancer patients at the end of life.

Saved in:
Bibliographic Details
Title: Scoping review of anticancer drug utilization in lung cancer patients at the end of life.
Authors: Szigethy E; PhD Programme in Biomedical Research Methodology and Public Health, Universitat Autònoma de Barcelona, Barcelona, Spain. Endre.Szigethy@autonoma.cat.; Epidy Kft, Csúcs Utca 9, Debrecen, 4034, Hungary. Endre.Szigethy@autonoma.cat., Merzah M; Epidy Kft, Csúcs Utca 9, Debrecen, 4034, Hungary.; Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Technical Institute of Karbala, Al Furat Al Awsat Technical University, Kufa, Iraq., Sola I; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain., Urrútia G; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain., Bonfill X; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Autònoma de Barcelona, Barcelona, Spain.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2025 May; Vol. 27 (5), pp. 1980-1993. Date of Electronic Publication: 2024 Oct 05.
Publication Type: Journal Article; Scoping Review
Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first